Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sofia Kagan"'
Autor:
Veronica Renteria, Amit G. Singal, Lin Li, Hao Zhu, Sofia Kagan, Hyesun Yoo, Purva Gopal, Tianshi Lu, Matthew R. Porembka, Akbar K. Waljee, Sam C. Wang, Tao Wang, Min Zhu, Nicole E. Rich, Mobolaji Odewole, Ji Zhu, Adam C. Yopp
Publikováno v:
Hepatology
Background and aims Several major factors limit our understanding of hepatocellular carcinoma (HCC). First, human HCCs are infrequently biopsied for diagnosis and thus are not often biologically interrogated. Second, HCC initiation and progression ar
Autor:
Nicole E. Rich, Reena Salgia, Janice H. Jou, Ruben Hernaez, Amit G. Singal, Neil Mehta, Christina C. Lindenmeyer, Andres Duarte-Rojo, Whitney E. Jackson, Avegail Flores, George N. Ioannou, Ponni V. Perumalswami, Sofia Kagan, Steven Scaglione, Sheila Eswaran, Hrishikesh Samant, Renumathy Dhanasekaran, Oren K. Fix, Shaun Chandna, Laura Kulik, Anjana Pillai, Jorge A. Marrero, Adnan Said, Sanjaya K. Satapathy, Maarouf Hoteit, Prasun K. Jalal, Elizabeth X. Zheng, Naim Alkhouri, Catherine Frenette, Russell Rosenblatt, Nayan M. Patel, Devika Kapuria, Z. Gordon Jiang, Amol S. Rangnekar, Ju Dong Yang, Neehar D. Parikh, Omobonike Oloruntoba, Binu John, Parvez S. Mantry, Veeral Ajmera, Mina Rakoski, James Hanje, Andrew M. Moon, Mobolaji Odewole, Michael D. Leise, Nyan L. Latt, Robert J. Wong
Publikováno v:
Clin Gastroenterol Hepatol
Background & Aims Direct-acting antivirals (DAAs) are effective against hepatitis C virus and sustained virologic response is associated with reduced incidence of hepatocellular carcinoma (HCC). However, there is controversy over the use of DAAs in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15b6475f93447f0368531c75532c44b8
Autor:
Amit G. Singal, Mengmeng Wang, Mobolaji Odewole, David M. Lubman, Neehar D. Parikh, Sofia Kagan, Suyu Liu, Veronica Renteria, Jing Liang, Jianhui Zhu
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-13 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-13 (2019)
A mass spectrometric analysis platform has been developed to determine whether glycosylation patterns of alpha-1 acid glycoprotein (AGP) could be used as a marker for early detection of hepatocellular carcinoma (HCC) in different etiologies, i.e. non
Autor:
Caitlin C. Murphy, Andres Duarte-Rojo, Reena Salgia, Omobonike Oloruntoba, Annsa Huang, Sofia Kagan, Michael D. Leise, Jordan J. Feld, Parvez S. Mantry, Purva Gopal, Hrishikesh Samant, Neil Mehta, Renumathy Dhanasekaran, Adnan Said, Laura Kulik, Sheila Eswaran, Steven Scaglione, Jennifer Guy, Binu John, Anjana Pillai, Kalyan Ram Bhamidimarri, Michael L. Volk, Andrea D. Branch, Janice H. Jou, Prasun K. Jalal, Maarouf Hoteit, Catherine Frenette, Robert J. Wong, Mobolaji Odewole, Amit G. Singal, Amol S. Rangnekar, George N. Ioannou, Neehar D. Parikh, Nicole E. Rich, Avegail Flores, Tram Tran, Sanjaya K. Satapathy
Publikováno v:
Gastroenterology, vol 157, iss 5
Background & Aims There is controversy regarding the benefits of direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection for patients with a history of hepatocellular carcinoma (HCC). We performed a multicenter cohort study to com